Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.91M | 12.16M | 18.21M | 21.86M | 19.95M |
| Total Depreciation and Amortization | 14.93M | 12.69M | 13.06M | 13.93M | 13.82M |
| Total Amortization of Deferred Charges | -- | 1.55M | 1.58M | -- | -- |
| Total Other Non-Cash Items | 2.35M | 640.00K | 4.46M | -131.00K | 1.37M |
| Change in Net Operating Assets | -15.99M | -13.23M | 4.65M | 5.94M | -6.65M |
| Cash from Operations | 22.20M | 13.81M | 41.95M | 41.60M | 28.48M |
| Capital Expenditure | -10.22M | -3.69M | -4.89M | -8.85M | -10.89M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.02M | -3.24M | 8.28M | -1.13M | -2.60M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.88M | -4.71M | 1.40M | -77.00K | 114.00K |
| Cash from Investing | -7.36M | -11.64M | 4.79M | -10.06M | -13.37M |
| Total Debt Issued | 57.76M | 8.71M | -21.68M | -- | -- |
| Total Debt Repaid | -69.38M | -6.46M | -6.33M | -29.71M | -15.14M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.00M | -1.28M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -- | -9.65M | -- | -- |
| Cash from Financing | -14.63M | 969.00K | -37.66M | -29.71M | -15.14M |
| Foreign Exchange rate Adjustments | 2.14M | 2.47M | -4.13M | 2.17M | -118.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.35M | 5.61M | 4.96M | 3.99M | -144.00K |